2007 Ron Paul 14:1
Mr. PAUL. Mr. Speaker, H.R. 4 gives the Secretary of Health and Human Services the
authority to engage in direct negotiations with
pharmaceutical companies regarding the
prices the companies will charge Medicare
when the companies provide drugs through
the Part D program. Contrary to the claims of
its opponents, this bill does not interfere with
a free market by giving the government new
power to impose price controls. Before condemning
this bill for creating price controls
or moving toward socialized medicine, my
colleagues should keep in mind that there is
not, and cannot be, a free market price for a
government-subsidized good.
2007 Ron Paul 14:2
Members concerned about preserving a free market in pharmaceuticals should have opposed
the legislation creating Part D in 2003.
It is odd to hear champions of the largest, and
most expensive, federal entitlement program
since the Great Society pose as defenders of
the free market.
2007 Ron Paul 14:3
The result of subsidizing the demand for prescription drugs through Part D was to raise
prices above what they would be in a free
market. This was easily foreseeable to anyone
who understands basic economics. Direct negotiation
is a means of ensuring that the increase
in demand does not unduly burden taxpayers
and that, pharmaceutical companies,
while adequately compensated, they do not
obtain an excessive amount of Medicare
funds.
2007 Ron Paul 14:4
The argument that direct negotiations will restrict Medicare beneficiaries access to the
prescription drugs of their choice assumes that
the current Part D system gives seniors control
over what pharmaceuticals they can use.
However, under Part D, seniors must enroll in
HMO-like entities that decide for them what
drugs they can and cannot obtain. My district
office staff has heard from numerous seniors
who are unable to obtain their drugs of choice
from their Part D providers. Mr. Speaker, I
favor reforming Medicare to give seniors more
control and choice in their health care, and, if
H.R. 4 were a threat to this objective, I would
oppose it.
2007 Ron Paul 14:5
Federal spending on Part D is expected to grow by $100 billion in 2007. It would be fiscally
irresponsible for this Congress not to act
to address those costs. I recognize that giving
the Department of Health and Human Services
the authority to engage in direct negotiations
neither fixes the long-term problems with
Medicare nor does empowers senior to control
their own health care. However, we are not
being given the opportunity to vote for a true
pro-freedom, pro-senior alternative today. Instead,
we are asked to choose between two
flawed proposals — keeping Part D as it is or
allowing the Department of Health and Human
Services to negotiate prescription drug prices
for the Part D program. Since I believe that direct
negotiations will benefit taxpayers and
Medicare beneficiaries by reducing the costs
of prescription drugs, I intend to vote for this
bill.